{"generic":"Emedastine Difumarate","drugs":["Emadine","Emedastine Difumarate"],"mono":{"0":{"id":"924690-s-0","title":"Generic Names","mono":"Emedastine Difumarate"},"1":{"id":"924690-s-1","title":"Dosing and Indications","sub":{"0":{"id":"924690-s-1-4","title":"Adult Dosing","mono":"<b>Allergic conjunctivitis:<\/b> 1 drop 0.05% ophthalmic solution in affected EYE(s) up to four times daily "},"1":{"id":"924690-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>safety and efficacy not established in children less than 3 years of age<\/li><li><b>Allergic conjunctivitis:<\/b> (3 yrs and older) 1 drop 0.05% ophthalmic solution in affected EYE(s) up to four times daily<\/li><\/ul>"},"3":{"id":"924690-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Allergic conjunctivitis<br\/><b>Non-FDA Labeled Indications<\/b><br\/>Asthma; Adjunct<br\/>"}}},"3":{"id":"924690-s-3","title":"Contraindications\/Warnings","sub":[{"id":"924690-s-3-9","title":"Contraindications","mono":"hypersensitivity to emedastine products<br\/>"},{"id":"924690-s-3-10","title":"Precautions","mono":"<ul><li>ophthalmic solution contains benzalkonium chloride which may be absorbed by soft contact lenses<\/li><li>prevent contamination of dropper tip and solution<\/li><li>wait at least 10 minutes after instillation of emedastine drops to insert contact lenseswait at least 10 minutes after instillation of emedastine drops to insert contact lenseswait at least 10 minutes after instillation of emedastine drops to insert contact lenses<\/li><\/ul>"},{"id":"924690-s-3-11","title":"Pregnancy Category","mono":"Emedastine: B (FDA)<br\/>"},{"id":"924690-s-3-12","title":"Breast Feeding","mono":"Emedastine: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"924690-s-4","title":"Drug Interactions","sub":{"1":{"id":"924690-s-4-14","title":"Major","mono":"<ul><li>Bupropion (theoretical)<\/li><li>Donepezil (theoretical)<\/li><\/ul>"}}},"5":{"id":"924690-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Neurologic:<\/b>Headache<br\/>"},"6":{"id":"924690-s-6","title":"Drug Name Info","sub":{"0":{"id":"924690-s-6-17","title":"US Trade Names","mono":"Emadine<br\/>"},"2":{"id":"924690-s-6-19","title":"Class","mono":"<ul><li>Antihistamine<\/li><li>Ophthalmologic Agent<\/li><\/ul>"},"3":{"id":"924690-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"924690-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"924690-s-7","title":"Mechanism Of Action","mono":"Emedastine difumarate selectively inhibits the H(1) histamine receptor, thus antagonizing histamine-stimulated vascular permeability in the conjunctiva when administered topically to the eyes. It lacks effects on adrenergic, dopaminergic, and serotonin receptors.<br\/>"},"8":{"id":"924690-s-8","title":"Pharmacokinetics","sub":{"2":{"id":"924690-s-8-25","title":"Metabolism","mono":"Metabolites: 5- and 6-hydroxyemedastine <br\/>"},"3":{"id":"924690-s-8-26","title":"Excretion","mono":"Renal: (Oral), approximately 44%, 3.6% unchanged <br\/>"},"4":{"id":"924690-s-8-27","title":"Elimination Half Life","mono":"(Oral), 3 h to 4 h <br\/>"}}},"9":{"id":"924690-s-9","title":"Administration","mono":"<b>Ophthalmic<\/b><br\/>remove contact lenses prior to instillation; may reinsert after 10 min of administration <br\/>"},"10":{"id":"924690-s-10","title":"Monitoring","mono":"reduction in ocular itching and irritation<br\/>"},"11":{"id":"924690-s-11","title":"How Supplied","mono":"<b>Emadine<\/b><br\/>Ophthalmic Solution: 0.05 %<br\/>"},"13":{"id":"924690-s-13","title":"Clinical Teaching","mono":"<ul><li>Instruct patient on proper instillation technique.<\/li><li>Advise patient to remove contact lenses prior to instilling drug. Lenses may be reinserted 10 min following instillation.<\/li><\/ul>"}}}